Cargando…

Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts

The extent of continuance of melatonin therapy initiated in pre-pubertal children with chronic sleep onset insomnia (CSOI) was investigated in young adult life. Sleep timing, sleep quality, adverse events, reasons for cessation of therapy, and patient characteristics with regard to therapy regimen,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwart, Tom C., Smits, Marcel G., Egberts, Toine C.G., Rademaker, Carin M.A., van Geijlswijk, Ingeborg M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872230/
https://www.ncbi.nlm.nih.gov/pubmed/29498667
http://dx.doi.org/10.3390/healthcare6010023
_version_ 1783309791185076224
author Zwart, Tom C.
Smits, Marcel G.
Egberts, Toine C.G.
Rademaker, Carin M.A.
van Geijlswijk, Ingeborg M.
author_facet Zwart, Tom C.
Smits, Marcel G.
Egberts, Toine C.G.
Rademaker, Carin M.A.
van Geijlswijk, Ingeborg M.
author_sort Zwart, Tom C.
collection PubMed
description The extent of continuance of melatonin therapy initiated in pre-pubertal children with chronic sleep onset insomnia (CSOI) was investigated in young adult life. Sleep timing, sleep quality, adverse events, reasons for cessation of therapy, and patient characteristics with regard to therapy regimen, chronotype and lifestyle factors possibly influencing sleeping behavior were assessed. With an online survey using questionnaires (Pittsburgh Sleep Quality Index, Insomnia Severity Index, Morningness-Eveningness Questionnaire, and Munich Chronotype Questionnaire), outcomes were measured and compared with age-related controls. These controls were extracted from published epidemiological research programs applying the same questionnaires. At the moment of the survey, melatonin was still continued by 27.3% of the patients, with a mean treatment duration of 10.8 years. The overall average treatment duration was 7.1 years. Sleep quality of both discontinued and persistent melatonin users did not deviate from controls. Sleep timing and chronotype scores indicated evening type preference in all responders. Adverse events were scarce but the perceived timing of pubertal development suggested a tendency towards delayed puberty in former and current users of melatonin. This study may underestimate the number of children that are able to stop using melatonin due to the response rate (47.8%) and appeal for continuing users. Sleep timing parameters were based on self-reported estimates. Control populations were predominantly students and were of varying nationalities. The statistical power of this study is low due to the limited sample size. Melatonin therapy sustained for 7.1 years does not result in substantial deviations of sleep quality as compared to controls and appears to be safe. The evening type preference suggests a causal relation with CSOI. This study shows that ten years after initiation of treatment with melatonin for CSOI, approximately 75% of the patients will have normal sleep quality without medication.
format Online
Article
Text
id pubmed-5872230
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58722302018-03-29 Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts Zwart, Tom C. Smits, Marcel G. Egberts, Toine C.G. Rademaker, Carin M.A. van Geijlswijk, Ingeborg M. Healthcare (Basel) Article The extent of continuance of melatonin therapy initiated in pre-pubertal children with chronic sleep onset insomnia (CSOI) was investigated in young adult life. Sleep timing, sleep quality, adverse events, reasons for cessation of therapy, and patient characteristics with regard to therapy regimen, chronotype and lifestyle factors possibly influencing sleeping behavior were assessed. With an online survey using questionnaires (Pittsburgh Sleep Quality Index, Insomnia Severity Index, Morningness-Eveningness Questionnaire, and Munich Chronotype Questionnaire), outcomes were measured and compared with age-related controls. These controls were extracted from published epidemiological research programs applying the same questionnaires. At the moment of the survey, melatonin was still continued by 27.3% of the patients, with a mean treatment duration of 10.8 years. The overall average treatment duration was 7.1 years. Sleep quality of both discontinued and persistent melatonin users did not deviate from controls. Sleep timing and chronotype scores indicated evening type preference in all responders. Adverse events were scarce but the perceived timing of pubertal development suggested a tendency towards delayed puberty in former and current users of melatonin. This study may underestimate the number of children that are able to stop using melatonin due to the response rate (47.8%) and appeal for continuing users. Sleep timing parameters were based on self-reported estimates. Control populations were predominantly students and were of varying nationalities. The statistical power of this study is low due to the limited sample size. Melatonin therapy sustained for 7.1 years does not result in substantial deviations of sleep quality as compared to controls and appears to be safe. The evening type preference suggests a causal relation with CSOI. This study shows that ten years after initiation of treatment with melatonin for CSOI, approximately 75% of the patients will have normal sleep quality without medication. MDPI 2018-03-02 /pmc/articles/PMC5872230/ /pubmed/29498667 http://dx.doi.org/10.3390/healthcare6010023 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zwart, Tom C.
Smits, Marcel G.
Egberts, Toine C.G.
Rademaker, Carin M.A.
van Geijlswijk, Ingeborg M.
Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title_full Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title_fullStr Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title_full_unstemmed Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title_short Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
title_sort long-term melatonin therapy for adolescents and young adults with chronic sleep onset insomnia and late melatonin onset: evaluation of sleep quality, chronotype, and lifestyle factors compared to age-related randomly selected population cohorts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872230/
https://www.ncbi.nlm.nih.gov/pubmed/29498667
http://dx.doi.org/10.3390/healthcare6010023
work_keys_str_mv AT zwarttomc longtermmelatonintherapyforadolescentsandyoungadultswithchronicsleeponsetinsomniaandlatemelatoninonsetevaluationofsleepqualitychronotypeandlifestylefactorscomparedtoagerelatedrandomlyselectedpopulationcohorts
AT smitsmarcelg longtermmelatonintherapyforadolescentsandyoungadultswithchronicsleeponsetinsomniaandlatemelatoninonsetevaluationofsleepqualitychronotypeandlifestylefactorscomparedtoagerelatedrandomlyselectedpopulationcohorts
AT egbertstoinecg longtermmelatonintherapyforadolescentsandyoungadultswithchronicsleeponsetinsomniaandlatemelatoninonsetevaluationofsleepqualitychronotypeandlifestylefactorscomparedtoagerelatedrandomlyselectedpopulationcohorts
AT rademakercarinma longtermmelatonintherapyforadolescentsandyoungadultswithchronicsleeponsetinsomniaandlatemelatoninonsetevaluationofsleepqualitychronotypeandlifestylefactorscomparedtoagerelatedrandomlyselectedpopulationcohorts
AT vangeijlswijkingeborgm longtermmelatonintherapyforadolescentsandyoungadultswithchronicsleeponsetinsomniaandlatemelatoninonsetevaluationofsleepqualitychronotypeandlifestylefactorscomparedtoagerelatedrandomlyselectedpopulationcohorts